ArticleJournal of the Endocrine Society2025
Serum Vitamin D Levels Over Time and the Incidence of Atrial Fibrillation in the HUNT Study.
Article in Journal of the Endocrine Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association Between Vitamin D Deficiency and the Incidence of Atrial Fibrillation: A Systematic Review and Meta-Analysis.Biomedicines · 2026Review
- Serum Vitamin D Levels Over Time and the Incidence of Atrial Fibrillation in the HUNT Study.Journal of the Endocrine Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Evidence of the association between serum vitamin D levels and atrial fibrillation (AF) is inconclusive. Thus, this study investigated the relationship between long-term average serum 25-hydroxyvitamin D [25(OH)D] levels and AF incidence in the Norwegian Trøndelag Health (HUNT) Study using a prospective cohort design and a Mendelian randomization (MR) approach. Methods: A total of 3394 adults with 2 measurements of serum 25(OH)D at HUNT2 (1995-1997) and HUNT3 (2006-2008) and without AF at HUNT3 were followed up to 2021. Average serum 25(OH)D levels over 10 years were categorized into <50 and ≥50 nmol/L. AF diagnoses were retrieved from hospital registers and validated by doctors. Cox regression was used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). Furthermore, a 1-sample MR was conducted among 36 554 adults who participated in both HUNT2 and HUNT3 using the Wald ratio method. Results: During a median 12-year follow-up, 304 AF cases were diagnosed. Serum 25(OH)D levels <50.0 nmol/L were associated with a 27% reduced incidence of AF (HR 0.73, 95% CI 0.57-0.93) compared with ≥50 nmol/L after adjustment for confounders. A genetically determined 10 nmol/L decrease in the serum 25(OH)D levels was associated with a 7% reduced incidence of AF (HR 0.93, 95% CI 0.86-1.00) in the 1-sample MR. Sensitivity analyses supported this association. Conclusion: Using both traditional observational and 1-sample MR approaches, the study suggested a consistently positive association between long-term average serum 25(OH)D levels and incidence of AF in the Norwegian HUNT population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.